Sean Murray

• Representing DIRECTV in lawsuits alleging antitrust and other claims against broadcasters, including In re Nexstar-TEGNA Merger Litig., No. 26-cv-976 (E.D. Cal.) and DIRECTV v. Nexstar Media Group, Inc. et al., No. 23-cv-2221-PKC (S.D.N.Y.)
• Defending The Southern Company in a lawsuit alleging antitrust claims related to nuclear employee compensation styled Dorrell et al. v. Constellation Energy Corp. et al., No. 25-cv-2251-ABA (D. Md.)
• Defended Google in several lawsuits alleging antitrust and other claims related to Google’s digital advertising technology, including multidistrict litigation styled In re Google Digital Advertising Antitrust Litig., No. 21-md-3010-PKC (S.D.N.Y.)
• Represented AT&T in its recent $5.75 billion acquisition of Lumen Technologies’ Mass Markets Fiber-to-the-home business.
• Defended Pfizer in several lawsuits alleging antitrust and other claims related to Hatch-Waxman Act litigation, including In re Lipitor Antitrust Litig., No. 12-cv-2389 (D.N.J.) and In re EpiPen Marketing, Sales Practices & Antitrust Litig., No. 17-md-2785 (D. Kan.)
• Defended a leading clearing broker in litigation and other matters involving antitrust and other claims related to meme-stock trading.
• Defended a global bank in several lawsuits alleging antitrust and other claims related to benchmark interest rates
• Represented a leading petrochemical company in connection with multijurisdictional merger compliance.

Sean Murray is a seasoned antitrust attorney and litigator, bringing a forward-thinking approach to a practice encompassing bet-the-company litigation, merger reviews, government investigations, and counseling.   He has broad experience representing international clients from a variety of industries, including financial services, pharmaceuticals, healthcare & medical devices, oil & gas and petrochemicals, food products, lab instruments, advertising technology, and telecommunications.

Select experience includes:

• Defending Google in several lawsuits alleging antitrust and other claims related to Google’s digital advertising technology, including multidistrict litigation styled In re Google Digital Advertising Antitrust Litig., No. 21-md-3010-PKC (S.D.N.Y.);
• Defending Pfizer in several lawsuits alleging antitrust and other claims related to Hatch-Waxman Act litigation, including In re Lipitor Antitrust Litig., No. 12-cv-2389 (D.N.J.) and In re EpiPen Marketing, Sales Practices & Antitrust Litig., No. 17-md-2785 (D. Kan.);
• Defending a global bank in several lawsuits alleging antitrust and other claims related to benchmark interest rates;
• Defending a leading clearing broker in litigation and other matters involving antitrust and other claims related to meme-stock trading; and
• Representing a leading petrochemical company in connection with multijurisdictional merger compliance.

Sean maintains an active pro bono practice, having represented clients in immigration, housing, and small contractual dispute matters, as well as former service members pursuing claims before the U.S. Department of Veterans’ Affairs.

He also has prior professional experience at the Department of Justice Antitrust Division, the Federal Trade Commission, and, before law school, a leading economic consulting firm where he worked with economists on merger reviews and antitrust, intellectual property, and mass tort litigation.